Immatics IMTX
NASDAQ IMTX
$9.45 -0.01 (-0.11%)
As of: Sep 4, 2026 · 3:21 PM EDT

Immatics (IMTX) Profit After Tax (2019 - 2026)

Immatics (IMTX) posted Profit After Tax of -$41.6 million for Q4 2025, up 29.68% sequentially from -$59.1 million in Q3 2025, and down 195.42% YoY from $43.6 million in Q4 2024.

Analysis

Immatics (IMTX) Profit After Tax (2019 - 2026) Analysis & Trends

Immatics has reported Profit After Tax for 7 years, with the latest figure at -$41.6 million in Q4 2025.

  • Quarterly Profit After Tax fell 195.42% year-over-year to -$41.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$222.2 million (down 1496.09% YoY) and the FY2025 annual result came in at -$221.9 million, down 1447.51% from the prior year.
  • Profit After Tax grew to -$41.6 million in Q4 2025 per IMTX's latest filing, from -$59.1 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $43.6 million in Q4 2024 and troughed at -$79.6 million in Q2 2025.
  • A 5-year average of -$19.9 million and a median of -$20.6 million in 2022 frame the typical range for Profit After Tax.
  • The widest YoY moves for Profit After Tax: up 279.64% in 2023, down 1388698.56% in 2023.
  • Over 5 years, Profit After Tax stood at -$19.2 million in 2021, then surged by 111.78% to $2.3 million in 2022, then plunged by 1232.27% to -$25.6 million in 2023, then soared by 270.05% to $43.6 million in 2024, then slumped by 195.42% to -$41.6 million in 2025.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$41.6 million, -$59.1 million, and -$79.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn 472.00 Mn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn - -644.37 Mn
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 81.49 Mn
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -16.62 Mn
10 Immatics 1.15 Bn 695.92 Mn - -72.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -72.64 Mn
Mar 31, 2026 -67.69 Mn
Dec 31, 2025 -39.08 Mn
Sep 30, 2025 -59.09 Mn
Jun 30, 2025 -79.63 Mn
Mar 31, 2025 -42.97 Mn
Dec 31, 2024 39.69 Mn
Sep 30, 2024 -5.83 Mn
Jun 30, 2024 -19.38 Mn
Mar 31, 2024 -2.43 Mn
Dec 31, 2023 -25.61 Mn
Sep 30, 2023 -28.84 Mn
Jun 30, 2023 26.80 Mn
Mar 31, 2023 -21.20 Mn
Dec 31, 2022 -13.50 Mn
Sep 30, 2022 -21.11 Mn
Jun 30, 2022 14.92 Mn
Mar 31, 2022 96.14 Mn
Dec 31, 2021 -19.20 Mn
Sep 30, 2021 -32.08 Mn